Hubing Shi

12.3k total citations · 9 hit papers
83 papers, 7.5k citations indexed

About

Hubing Shi is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Hubing Shi has authored 83 papers receiving a total of 7.5k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Molecular Biology, 35 papers in Oncology and 13 papers in Cancer Research. Recurrent topics in Hubing Shi's work include Melanoma and MAPK Pathways (15 papers), Cancer Immunotherapy and Biomarkers (13 papers) and Nanoplatforms for cancer theranostics (9 papers). Hubing Shi is often cited by papers focused on Melanoma and MAPK Pathways (15 papers), Cancer Immunotherapy and Biomarkers (13 papers) and Nanoplatforms for cancer theranostics (9 papers). Hubing Shi collaborates with scholars based in China, United States and Australia. Hubing Shi's co-authors include Roger S. Lo, Xiangju Kong, Antoni Ribas, Jeffrey A. Sosman, Richard C. Koya, Thinle Chodon, Hane Lee, Mi‐Kyung Lee, Stanley F. Nelson and Gatien Moriceau and has published in prestigious journals such as Nature, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Hubing Shi

78 papers receiving 7.4k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Melanomas acquire resistance to B-RAF(V600E) inhibition by RTK or N-RAS upregulation

2010 1.6k citations Ramin Nazarian, Hubing Shi et al. profile →
Acquired Resistance and Clonal Evolution in Melanoma during BRAF Inhibitor Therapy

2013 715 citations Hubing Shi, Willy Hugo et al. Cancer Discovery profile →
Melanoma whole-exome sequencing identifies V600EB-RAF amplification-mediated acquired B-RAF inhibitor resistance

2012 470 citations Hubing Shi, Gatien Moriceau et al. Nature Communications profile →
Non-genomic and Immune Evolution of Melanoma Acquiring MAPKi Resistance

2015 412 citations Willy Hugo, Hubing Shi et al. profile →
Inhibiting PD-L1 palmitoylation enhances T-cell immune responses against tumours

2019 403 citations Hubing Shi et al. profile →
Therapy-induced tumour secretomes promote resistance and tumour progression

2015 364 citations Hubing Shi, Xiangju Kong et al. profile →
Immune checkpoint HLA-E:CD94-NKG2A mediates evasion of circulating tumor cells from NK cell surveillance

2023 217 citations Xiaowei Liu, Jinen Song et al. profile →
Artificial intelligence-based multi-omics analysis fuels cancer precision medicine

2022 202 citations Xiujing He, Xiaowei Liu et al. profile →
Real-time detection of 20 amino acids and discrimination of pathologically relevant peptides with functionalized nanopore

2024 67 citations Ming Zhang, Chao Tang et al. Nature Methods profile →

Peers

Countries citing papers authored by Hubing Shi

Since Specialization

Citations

This map shows the geographic impact of Hubing Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hubing Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hubing Shi more than expected).

Fields of papers citing papers by Hubing Shi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hubing Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hubing Shi. The network helps show where Hubing Shi may publish in the future.

Co-authorship network of co-authors of Hubing Shi

This figure shows the co-authorship network connecting the top 25 collaborators of Hubing Shi. A scholar is included among the top collaborators of Hubing Shi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hubing Shi. Hubing Shi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Promotion of triple negative breast cancer immunotherapy by combining bioactive radicals with immune checkpoint blockade 2025 ·Acta Biomaterialia ·Meixu Chen, Linlin Song, Ruhong Zhou, Tianyue Xu, Ting Sun, Zhihui Liu, Zihan Xu, (unknown), Peixin Du, Yingying Ma, Li‐Wen Huang, Xiaoting Chen, Guang Yang, Jing Jing, Hubing Shi	5
2	A cisplatin prodrug-based self-assembling ozone delivery nanosystem sensitizes radiotherapy in triple-negative breast cancer 2025 ·Acta Pharmaceutica Sinica B ·(unknown), (unknown), Meixu Chen, Linlin Song, Zhihui Liu, Cheng Yan, (unknown), Li‐Wen Huang, Xingwen Li, (unknown), Cong Li, (unknown), Jing Jing, Hubing Shi	0
3	Single-cell transcriptional dissection illuminates an evolution of immunosuppressive microenvironment during pancreatic ductal adenocarcinoma metastasis 2025 ·Signal Transduction and Targeted Therapy ·Xiaowei Liu, Jinen Song, (unknown), (unknown), Huihui Li, (unknown), Xinmin Wang, Xueyan Wang, Qian Xiao, Li Li, Xinyu Liu, (unknown), Jian‐Lin Wu, Jing Jing, Xuelei Ma, Hubing Shi	2
4	The Immunomechanical Checkpoint PYK2 Governs Monocyte-to-Macrophage Differentiation in Pancreatic Cancer 2025 ·Cancer Discovery ·Wenyan Xie, Xin Yu, (unknown), Nengwen Ke, (unknown), Hao Kong, Xiangji Wu, (unknown), Lang Chen, (unknown), (unknown), Yuan Wang, Hubing Shi, Lu Chen, (unknown), Bi‐Sen Ding, Qiang Wei, Hong Jiang	6
5	Intrapleural pressure-controlled piezo-catalytic nanozyme for the inhibition of malignant pleural effusion 2025 ·Nature Communications ·Zihan Xu, Xiujing He, Yu Gui, (unknown), (unknown), Linlin Song, (unknown), Meixu Chen, Yujie Zhao, Peixin Du, Xin Wang, (unknown), Yong Luo, Feng Luo, Huan Meng, (unknown), Wei Zhuo, Jing Jing, Hubing Shi	2
6	Enhancing genome‐wide populus trait prediction through deep convolutional neural networks 2024 ·The Plant Journal ·(unknown), (unknown), (unknown), Cheng Yan, (unknown), (unknown), Yunguo Liu, Feng Wang, Hubing Shi, Jianping Hu	2
7	Development and validation of a point‐of‐care nursing mobile tool to guide the diagnosis of malnutrition in hospitalized adult patients: a multicenter, prospective cohort study 2024 ·SHILAP Revista de lepidopterología ·(unknown), Xueyan Zhou, Weichang Chen, (unknown), Xiaoxuan Wang, Yuhao Wei, (unknown), Tao Shen, (unknown), Chan Yang, Tingting Dai, Hao Zhang, Hubing Shi, Xuelei Ma	1
8	Real-time detection of 20 amino acids and discrimination of pathologically relevant peptides with functionalized nanopore breakdown → 2024 ·Nature Methods ·Ming Zhang, Chao Tang, Zichun Wang, (unknown), (unknown), Kaiju Li, Ke Sun, Changjian Zhao, Yu Wang, Mengying Xu, Lunzhi Dai, Guangwen Lu, Hubing Shi, Haiyan Ren, Lu Chen, Jia Geng	67
9	Structural basis of the subcortical maternal complex and its implications in reproductive disorders 2024 ·Nature Structural & Molecular Biology ·(unknown), (unknown), Dandan Qin, Zhuo Han, Jialu Li, Qingjie Xiao, Zheng Gao, (unknown), Qianqian Qi, Qingting Liu, (unknown), Jinhong Li, Li Guo, (unknown), Jing Chen, Xiang Wang, Hubing Shi, Lei Li, Dong Deng	11
10	Exosome-mediated Delivery of miR-519e-5p Promotes Malignant Tumor Phenotype and CD8+ T-Cell Exhaustion in Metastatic PTC 2023 ·The Journal of Clinical Endocrinology & Metabolism ·Genpeng Li, Wenjie Chen, (unknown), Jing Huang, (unknown), Xiaowei Liu, Tao Wei, Rixiang Gong, Zhihui Li, Jingqiang Zhu, Hubing Shi, Jianyong Lei	14
11	The Evolution of Acquired Resistance to BRAFV600E kinase inhibitor Is Sustained by IGF1-Driven Tumor Vascular Remodeling 2021 ·Journal of Investigative Dermatology ·Guangchao Xu, Ya Luo, Wenshuang Wu, Xiaowei Liu, (unknown), Yu Bao, Xiujing He, Jing Yu, Yanna Li, Jiqiao Yang, Rongjie Zhang, Chune Yu, Hongying Chen, (unknown), (unknown), Jing Jing, Hubing Shi	15
12	Strategy used to synthesize high activity and low Pd catalyst for Suzuki coupling reaction: an experimental and theoretical investigation 2020 ·Physical Chemistry Chemical Physics ·Xiao Yan, (unknown), Wei Liu, Li Liang, (unknown), Zhong‐Zhu Chen, Zhigang Xu, (unknown), Dianyong Tang, Hubing Shi, Jianping Hu	11
13	Acquired Resistance and Clonal Evolution in Melanoma during BRAF Inhibitor Therapy breakdown → 2013 ·Cancer Discovery ·Hubing Shi, Willy Hugo, Xiangju Kong, Aayoung Hong, Richard C. Koya, Gatien Moriceau, Thinle Chodon, Rongqing Guo, Douglas B. Johnson, Kimberly B. Dahlman, Mark C. Kelley, Richard Kefford, Bartosz Chmielowski, John A. Glaspy, Jeffrey A. Sosman, Nicolas van Baren, Georgina V. Long, Antoni Ribas, Roger S. Lo	715
14	A Novel AKT1 Mutant Amplifies an Adaptive Melanoma Response to BRAF Inhibition 2013 ·Cancer Discovery ·Hubing Shi, Aayoung Hong, Xiangju Kong, Richard C. Koya, Chunying Song, Gatien Moriceau, Willy Hugo, Clarissa C. Yu, Charles Ng, Thinle Chodon, Richard A. Scolyer, Richard Kefford, Antoni Ribas, Georgina V. Long, Roger S. Lo	133
15	Preexisting MEK1 Exon 3 Mutations in V600E/K BRAF Melanomas Do Not Confer Resistance to BRAF Inhibitors 2012 ·Cancer Discovery ·Hubing Shi, Gatien Moriceau, Xiangju Kong, Richard C. Koya, Ramin Nazarian, Gulietta M. Pupo, Antonella Bacchiocchi, Kimberly B. Dahlman, Bartosz Chmielowski, Jeffrey A. Sosman, Ruth Halaban, Richard Kefford, Georgina V. Long, Antoni Ribas, Roger S. Lo	75
16	Combinatorial Treatments That Overcome PDGFRβ-Driven Resistance of Melanoma Cells to V600EB-RAF Inhibition 2011 ·Cancer Research ·Hubing Shi, Xiangju Kong, Antoni Ribas, Roger S. Lo	184
17	The Regulatory Mechanism of Extracellular Hsp90α on Matrix Metalloproteinase-2 Processing and Tumor Angiogenesis 2010 ·Journal of Biological Chemistry ·Xiaomin Song, Xiaofeng Wang, Wei Zhuo, Hubing Shi, Dan Feng, Yi Sun, Yun Liang, Yan Fu, (unknown), Yongzhang Luo	99
18	Pulmonary Vascular Destabilization in the Premetastatic Phase Facilitates Lung Metastasis 2009 ·Cancer Research ·Yujie Huang, Nan Song, Yanping Ding, Shaopeng Yuan, Xuhui Li, Hongchen Cai, Hubing Shi, Yongzhang Luo	181
19	The regulatory mechanism of Hsp90α secretion and its function in tumor malignancy 2009 ·Proceedings of the National Academy of Sciences ·Xiaofeng Wang, Xiaomin Song, Wei Zhuo, Yan Fu, Hubing Shi, Yun Liang, Maomeng Tong, Guodong Chang, Yongzhang Luo	218
20	Overexpression of Platelet-Derived Growth Factor-BB Increases Tumor Pericyte Content via Stromal-Derived Factor-1α/CXCR4 Axis 2009 ·Cancer Research ·Nan Song, Yujie Huang, Hubing Shi, Shaopeng Yuan, Yanping Ding, Xiaomin Song, Yan Fu, Yongzhang Luo	97

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact